PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.26%
Revenue growth 1.25-1.5x AVGO's 5.15%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
5.32%
Gross profit growth at 50-75% of AVGO's 7.72%. Martin Whitman would question if cost structure or brand is lagging.
5.90%
EBIT growth 50-75% of AVGO's 9.20%. Martin Whitman would suspect suboptimal resource allocation.
6.24%
Operating income growth at 50-75% of AVGO's 9.20%. Martin Whitman would doubt the firm’s ability to compete efficiently.
4.09%
Net income growth at 75-90% of AVGO's 4.77%. Bill Ackman would press for improvements to catch or surpass competitor performance.
4.20%
EPS growth under 50% of AVGO's 8.62%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.81%
Diluted EPS growth under 50% of AVGO's 8.93%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.04%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
-17.54%
Negative OCF growth while AVGO is at 21.72%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.16%
Negative FCF growth while AVGO is at 22.84%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
93.65%
10Y revenue/share CAGR under 50% of AVGO's 737.75%. Michael Burry would suspect a lasting competitive disadvantage.
52.48%
5Y revenue/share CAGR at 50-75% of AVGO's 90.54%. Martin Whitman would worry about a lagging mid-term growth trajectory.
44.72%
3Y revenue/share CAGR similar to AVGO's 42.56%. Walter Schloss would assume both companies experience comparable short-term cycles.
224.56%
10Y OCF/share CAGR under 50% of AVGO's 1099.59%. Michael Burry would worry about a persistent underperformance in cash creation.
108.31%
5Y OCF/share CAGR at 50-75% of AVGO's 164.09%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
0.26%
3Y OCF/share CAGR under 50% of AVGO's 54.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
536.51%
Net income/share CAGR at 50-75% of AVGO's 1053.02%. Martin Whitman might question if the firm’s product or cost base lags behind.
134.40%
Below 50% of AVGO's 479.97%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
78.80%
Below 50% of AVGO's 263.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
56.50%
Below 50% of AVGO's 477.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.19%
5Y equity/share CAGR above 1.5x AVGO's 6.47%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
69.13%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
573.58%
Below 50% of AVGO's 3162.35%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
129.97%
Below 50% of AVGO's 294.56%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
49.53%
3Y dividend/share CAGR at 75-90% of AVGO's 60.70%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
22.01%
AR growth well above AVGO's 21.43%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.75%
Inventory growth well above AVGO's 9.74%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.86%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-6.43%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
5.88%
R&D growth drastically higher vs. AVGO's 4.56%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
No Data
No Data available this quarter, please select a different quarter.